Literature DB >> 11680597

Hydrogen breath test with D-xylose for celiac disease screening is as useful in the elderly as in other age groups.

F Casellas1, J Sardi, I de Torres, J R Malagelada.   

Abstract

Up to one fifth of celiac disease patients are diagnosed after the age of 60. The hydrogen breath test with D-xylose as substrate (xylose-BT) has proved useful for the diagnosis of adult celiac disease. Our aim was to determine the potential influence of age-related intestinal mucosal changes on the reliability of this test. We reviewed the results of the xylose-BT in 50 patients with clinical celiac disease in whom the diagnosis was confirmed by histology. A control group of 53 patients with various diarrheal disorders and without jejunal mucosal atrophy at biopsy was similarly studied. Both celiac patients and controls were divided into adults (age < or = 60 years) and elderly (age >60 years). Seven of the 50 celiacs and 8 of the 53 controls were in the elderly category (P = NS). In the celiac disease group, no differences were observed between the elderly and adult patient subgroups for basal H2 excretion (22.4 +/- 42 vs 9.7 +/- 11 ppm), delta increase (56 +/- 43 vs 53 +/- 36 ppm), or area under the curve (7,452 +/- 5,546 vs 6,739 +/- 5,951 ppm x min). The false negative rate was similar for celiac adult (7/43) and elderly (2/7, P = ns) patients. Sensitivity of the xylose-BT was 0.83 in adults and 0.71 in the elderly, and specificity 0.51 in adults and 0.50 in the elderly. In conclusion, the results of the xylose-BT in celiac patients are not influenced by age. The xylose-BT is as valuable a tool for the screening of celiac disease in the elderly as it is in younger patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680597     DOI: 10.1023/a:1011967016189

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  Small bowel diseases in the elderly.

Authors:  A Nagar; I M Roberts
Journal:  Clin Geriatr Med       Date:  1999-08       Impact factor: 3.076

2.  Small bowel bacterial overgrowth in subjects living in residential care homes.

Authors:  S J Lewis; L F Potts; R Malhotra; R Mountford
Journal:  Age Ageing       Date:  1999-03       Impact factor: 10.668

3.  A CLINICAL EVALUATION OF THE D-XYLOSE TOLERANCE TEST.

Authors:  J M FINLAY; J HOGARTH; K J WIGHTMAN
Journal:  Ann Intern Med       Date:  1964-09       Impact factor: 25.391

Review 4.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

Review 5.  The aging gut. Nutritional issues.

Authors:  J R Saltzman; R M Russell
Journal:  Gastroenterol Clin North Am       Date:  1998-06       Impact factor: 3.806

6.  Diagnosis of celiac sprue.

Authors:  J S Trier
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

7.  Impact of age, sex, race, and functional complaints on hydrogen (H2) production.

Authors:  D M Saltzberg; G M Levine; C Lubar
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

8.  [Xylose test. Correlation with small bowel histology (author's transl)].

Authors:  D Turck; P Delattre; P Labbe; D Hauwe; J P Farriaux
Journal:  Ann Pediatr (Paris)       Date:  1980-12

9.  Conventional malabsorption tests: do they detect the adult patient with villous atrophy?

Authors:  R Gillberg; G Dotevall; W Kastrup; G Lindstedt; H Mobacken; B Swolin
Journal:  Scand J Clin Lab Invest       Date:  1984-02       Impact factor: 1.713

10.  The diagnostic value of the D-xylose absorption test in adult coeliac disease.

Authors:  S Bodé; E Gudmand-Høyer
Journal:  Scand J Gastroenterol       Date:  1987-12       Impact factor: 2.423

View more
  1 in total

1.  Influence of colectomy on hydrogen excretion in breath.

Authors:  Francesc Casellas; A Torrejón; J Vilaseca; A Aparici; M Casaus; P Rodríguez; F Guarner
Journal:  Int J Colorectal Dis       Date:  2009-11-10       Impact factor: 2.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.